Luminary Therapeutics, Inc. — Form D/A
Luminary Therapeutics, Inc. of Minneapolis, MN, a company, filed a Form D amendment with the SEC on 2023-08-03. The offering totals $3.5M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-03
- Form: D/A
- Accession: 0001437749-23-021823
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $2.4M
- Remaining: $1.1M
- Investors: 12
- Date of first sale: 2022-09-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-470421
Issuer
- Name: Luminary Therapeutics, Inc.
- CIK: 0001793860
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1200 Washington Avenue South, Minneapolis, MN, 55415
- Phone: 612-309-7653
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| David Largaespada | Director | Minneapolis, MN |
| Alexander Naydich | Director | Minneapolis, MN |
| John Hurley | Executive Officer | Minneapolis, MN |
| David Largaespada | Promoter | Minneapolis, MN |
| Branden Moriarity | Director | Minneapolis, MN |
| Mark Chance | Director | Minneapolis, MN |
| Tracey Lodie | Director | Minneapolis, MN |
| James Haymaker | Director | Minneapolis, MN |
| James Haymaker | Promoter | Minneapolis, MN |
| John Wells | Director | Minneapolis, MN |
| Jeff Ross | Director | Eden Prairie, MN |
| Jeff Liter | Director | Minneapolis, MN |
| Jeff Liter | Executive Officer | Minneapolis, MN |
| Jeff Liter | Promoter | Minneapolis, MN |
| David Largaespada | Executive Officer | Minneapolis, MN |
| Peter Kosa | Director | Minneapolis, MN |
| George Cox | Director | Minneapolis, MN |
| Jim Haymaker | Director | Minneapolis, MN |
Other filings by this issuer (7)
More